Recombinant UPF0178 protein yaiI (yaiI)

Shipped with Ice Packs
In Stock

Description

Introduction

Recombinant UPF0178 protein YaiI (YaiI) is a hypothetical protein encoded by the yaiI gene, classified under the UPF0178 family. It is expressed in bacterial species such as Escherichia coli O157:H7 and Salmonella typhimurium. This protein is of interest in structural and functional genomics due to its conserved but poorly characterized role in bacterial physiology .

Expression Systems and Purification

Recombinant YaiI is produced using multiple expression platforms to meet research demands:

ParameterDetails
Source OrganismEscherichia coli O157:H7, Salmonella typhimurium
Expression SystemsE. coli, Yeast, Baculovirus, Mammalian cells
TagHis-tag (common), AviTag (for biotinylation)
Purity≥85% (SDS-PAGE)
ReconstitutionLyophilized powder solubilized in sterile water or buffers

Functional Studies

  • Hypothetical Role: Predicted to participate in stress response or metabolic regulation, though mechanistic insights remain limited .

  • Interaction Networks: Computational models suggest associations with membrane transporters or redox enzymes .

Technical Uses

  • Antigen Production: Utilized for polyclonal antibody generation due to its immunogenicity .

  • Structural Biology: Serves as a target for X-ray crystallography or NMR to resolve 3D conformation .

Challenges and Future Directions

  • Functional Annotation: No direct experimental data on enzymatic activity or pathways .

  • Biotechnological Potential: Engineered variants could explore roles in synthetic biology or antimicrobial drug discovery .

Product Specs

Form
Lyophilized powder. We will ship the in-stock format preferentially. If you have special format requirements, please note them when ordering.
Lead Time
Delivery time varies based on purchasing method and location. Consult your local distributor for specific delivery times. All proteins are shipped with standard blue ice packs. Request dry ice in advance for an extra fee.
Notes
Avoid repeated freezing and thawing. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
yaiI; STY0420; t2477; UPF0178 protein YaiI
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-151
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Salmonella typhi
Target Names
yaiI
Target Protein Sequence
MTIWVDADAC PNVIKEILYR AAERMQLPLI LVANQALRVP PSRFIRTLRV AAGFDVADNE IVRQCEAGDL VITADIPLAA EVLEKGAAAL NPRGERYSDA TIRERLTMRD FMDTLRASGV QTGGPNTLSP RDRQHFAAEL DKWWLESQRK K
Uniprot No.

Q&A

What is the molecular structure of the UPF0178 protein yaiI?

UPF0178 protein yaiI is a full-length protein comprising 152 amino acids with a molecular weight of 16,969 Da. The complete amino acid sequence is: MTIWVDADACPNVIKEILYRAAE RMQMPLVLVANQSLRVPPSRFIRTLRVAAGFDVADNEIVRQCEAGDLVITADIPLAAE AIEKGAAALNPRGERYPTATIRERLTMRDFMDTLRASGIGTGGPDSLSQRDRQAFAAE LEKWWLEVQRSRG . The protein belongs to the UPF0178 family, with its structure suggesting potential roles in cellular processes that are still being elucidated through ongoing research.

Which expression systems are available for producing recombinant yaiI protein?

Recombinant UPF0178 protein yaiI can be produced using multiple expression systems, each offering different advantages for research applications:

Expression SystemProduct CodeSpecial Considerations
E. coliCSB-EP359116EODCost-effective, high yield for non-modified proteins
YeastCSB-YP359116EODBetter for certain post-translational modifications
BaculovirusCSB-BP359116EODInsect cell-based, complex eukaryotic modifications
Mammalian cellCSB-MP359116EODMost authentic post-translational modifications

Additionally, specialized variants such as Avi-tag Biotinylated versions (CSB-EP359116EOD-B) are available for applications requiring biotinylation .

What level of purity can be expected for commercially available recombinant yaiI?

Commercial preparations of recombinant UPF0178 protein yaiI typically achieve ≥85% purity as determined by SDS-PAGE analysis . This level of purity is generally sufficient for most biochemical and structural studies, though researchers requiring higher purity for specialized applications should consider additional purification steps following acquisition of the commercial product.

How should I design proteomics experiments involving yaiI protein?

When designing proteomics experiments involving yaiI protein, computer modeling and simulation approaches can significantly improve experimental outcomes. Begin by clearly defining your research question, then model the experimental parameters before performing wet-lab work. As noted in proteomics research literature, "The complexity of proteomes makes good experimental design essential for their successful investigation" .

Recommended approach:

  • Define specific objectives (interaction partners, structural features, etc.)

  • Create a computer simulation of your experimental design

  • Identify potential confounding variables

  • Include appropriate controls (negative controls, positive controls with known interactors)

  • Consider statistical power requirements for meaningful results

  • Implement iterative refinement based on preliminary data

What are the optimal buffer conditions for maintaining yaiI stability during experiments?

Based on protein characteristics and standard protocols for similar bacterial proteins, the following buffer conditions are recommended for maintaining yaiI stability:

Buffer ComponentRecommended RangeRationale
pH7.0-8.0Optimal for maintaining native structure
Salt (NaCl)100-300 mMProvides ionic strength without precipitation
Reducing agent1-5 mM DTT or TCEPPrevents unwanted disulfide formation
Glycerol5-10%Enhances stability for long-term storage
Protease inhibitorsAs per manufacturerPrevents degradation during experiments

Storage should be at -80°C for long-term or -20°C with glycerol for medium-term stability. Working solutions should be kept on ice to minimize degradation.

What approaches are most effective for determining the function of UPF0178 protein yaiI?

Given that yaiI is a protein of unknown function (UPF), a multi-faceted approach is recommended:

  • Computational prediction: Utilize structural homology modeling to predict function based on similar protein domains.

  • Interactome analysis: Identify binding partners through techniques such as:

    • Affinity purification coupled with mass spectrometry

    • Yeast two-hybrid screening

    • Protein microarrays using recombinant yaiI as bait

  • Genetic approaches:

    • Gene knockout/knockdown studies in E. coli

    • Complementation assays

    • Phenotypic screening under various stress conditions

  • Biochemical characterization:

    • Enzymatic activity assays based on predicted function

    • Substrate screening if enzymatic activity is suspected

This combined approach follows the "design cycle" principles where "theory and experiment alternate" to progressively build understanding of protein function .

How can I determine if my recombinant yaiI protein is properly folded?

Proper folding is essential for functional studies. Several complementary methods should be employed:

  • Circular Dichroism (CD) Spectroscopy: Provides information about secondary structural elements (α-helices, β-sheets).

  • Thermal Shift Assays: Measures protein stability and can indicate proper folding through determination of melting temperature.

  • Limited Proteolysis: Well-folded proteins typically show resistance to proteolytic digestion except at exposed loops.

  • Size Exclusion Chromatography: Can indicate if the protein exists as a monomer or forms aggregates that may suggest improper folding.

  • Activity Assays: If function is known or predicted, functional assays provide the most relevant indication of proper folding.

How can rational protein design principles be applied to modify yaiI for enhanced functionality?

Rational protein design for yaiI modification should follow the hierarchical approach described in the literature where "increasing levels of complexity are iteratively introduced" . This methodology involves:

  • Computational modeling: Create a molecular model based on the full sequence (MTIWVDADAC PNVIKEILYR AAERMQMPLV LVANQSLRVP PSRFIRTLRV AAGFDVADNE IVRQCEAGDL VITADIPLAA EAIEKGAAAL NPRGERYTPA TIRERLTMRD FMDTLRASGI QTGGPDSLSQ RDRQAFAAEL EKWWLEVQRS RG) .

  • Identify modification targets: Based on structural predictions, identify:

    • Surface residues for solubility enhancement

    • Core residues for stability modification

    • Active site residues (if known) for functional modification

  • Design mutants: Apply the "inverse folding" approach where you "keep [the backbone] fixed, and redecorate with different amino acid sequences that are predicted to be structurally compatible with that fold" .

  • Experimental validation: Produce and test modified variants, then:

    • Characterize structural changes

    • Assess functional impacts

    • Iterate design based on results

What approaches are recommended for resolving contradictory experimental data regarding yaiI function?

When faced with contradictory data regarding yaiI function, a systematic approach is necessary:

  • Data quality assessment:

    • Evaluate experimental reproducibility within and between labs

    • Assess reagent quality, particularly antibody specificity and protein purity

    • Review statistical analysis methods for potential biases

  • Experimental conditions comparison:

    • Create a comprehensive table of all experimental conditions (pH, temperature, buffer components, etc.)

    • Identify systematic differences that may explain divergent results

  • Theoretical framework evaluation:

    • Consider if contradictory results reflect different aspects of a multi-functional protein

    • Develop unifying hypotheses that accommodate seemingly contradictory data

  • Decisive experiments design:

    • Design experiments specifically to distinguish between competing hypotheses

    • Implement orthogonal techniques to validate findings

    • Consider in vivo relevance of in vitro findings

This approach reflects the scientific principle that contradictions often reveal new insights when properly investigated.

What are the most appropriate methods for identifying interaction partners of yaiI?

For identifying interaction partners of yaiI, a combination of complementary approaches yields the most reliable results:

  • Affinity-based methods:

    • Pull-down assays using recombinant biotinylated yaiI (CSB-EP359116EOD-B)

    • Co-immunoprecipitation with anti-yaiI antibodies

    • Protein microarrays with immobilized yaiI protein

  • Proximity-based methods:

    • Yeast two-hybrid screening

    • Bacterial two-hybrid systems (more relevant for bacterial proteins)

    • Proximity labeling approaches (BioID, APEX)

  • Biophysical interaction analysis:

    • Surface plasmon resonance (SPR)

    • Isothermal titration calorimetry (ITC)

    • Microscale thermophoresis (MST)

  • Computational prediction and validation:

    • Interactome database mining

    • Structural docking simulations

    • Functional association networks

Each method has distinct strengths and limitations, so concordance across multiple approaches provides the strongest evidence for genuine interactions.

How can I distinguish between specific and non-specific interactions in yaiI binding studies?

Distinguishing specific from non-specific interactions requires rigorous experimental controls and validation:

  • Control proteins:

    • Use structurally similar but functionally distinct proteins as negative controls

    • Include known interaction partners as positive controls

  • Competition assays:

    • Perform binding in the presence of increasing concentrations of unlabeled protein

    • Specific interactions show competitive displacement; non-specific don't

  • Mutational analysis:

    • Systematically mutate surface residues of yaiI

    • Specific interactions are disrupted by mutations at the interaction interface

  • Concentration dependence:

    • Specific interactions typically show saturable binding kinetics

    • Non-specific interactions often increase linearly with concentration

  • Stringency conditions:

    • Increase salt concentration and detergent levels to disrupt non-specific interactions

    • Specific interactions typically withstand moderate increases in stringency

What strategies can resolve common issues with recombinant yaiI expression and purification?

Common issues with yaiI expression and purification can be addressed through systematic troubleshooting:

IssuePotential Solutions
Low expression yield- Optimize codon usage for expression host
- Test different promoter systems
- Adjust induction conditions (temperature, inducer concentration)
- Consider fusion tags (MBP, SUMO) to enhance solubility
Protein insolubility- Reduce expression temperature (16-20°C)
- Add solubility enhancers to lysis buffer (0.1% Triton X-100, 10% glycerol)
- Co-express with chaperones
- Consider refolding from inclusion bodies
Proteolytic degradation- Add protease inhibitor cocktail
- Reduce purification time
- Keep samples cold throughout purification
- Consider C-terminal vs. N-terminal tags
Aggregation during storage- Add stabilizing agents (glycerol, trehalose)
- Optimize buffer conditions (pH, salt)
- Store at appropriate concentration (avoid too concentrated)
- Flash-freeze aliquots and avoid freeze-thaw cycles

For particularly difficult cases, switching expression systems may be necessary. The baculovirus or mammalian expression systems offered by suppliers may provide better results for challenging proteins .

How can I address reproducibility challenges in functional assays involving yaiI?

Reproducibility challenges in yaiI functional assays can be addressed through:

  • Standardization of reagents:

    • Use the same lot of recombinant protein when possible

    • Carefully document source, purity, and storage conditions

    • Create internal standards for normalization between experiments

  • Protocol documentation:

    • Develop detailed SOPs with explicit parameters

    • Record all environmental variables (temperature, humidity)

    • Use electronic lab notebooks for comprehensive documentation

  • Assay validation:

    • Determine assay precision through replicate measurements

    • Establish acceptance criteria before experiments

    • Include internal controls in every experiment

  • Statistical considerations:

    • Perform power analyses to determine appropriate sample sizes

    • Use appropriate statistical tests for data analysis

    • Consider blinding procedures for subjective measurements

  • Inter-laboratory validation:

    • Exchange protocols and samples with collaborating labs

    • Conduct parallel experiments to identify lab-specific variables

    • Develop robust assays that translate across different settings

This approach aligns with the principles of model-guided experimental design, where theory and experiment inform each other iteratively .

What are the emerging technologies that could advance our understanding of yaiI function?

Emerging technologies that could significantly advance yaiI research include:

  • AlphaFold2 and structural prediction:

    • Leverage AI-based structural prediction to generate high-confidence structural models

    • Use predicted structures to inform functional hypotheses and guide experimental design

  • Cryo-EM and advanced structural biology:

    • Determine high-resolution structures of yaiI alone and in complexes

    • Visualize dynamic conformational changes under different conditions

  • Single-molecule techniques:

    • Employ FRET and other single-molecule approaches to study dynamics

    • Investigate individual molecular events rather than ensemble averages

  • Genome-wide screening approaches:

    • CRISPR-based functional genomics to identify genetic interactions

    • High-throughput phenotypic screening under diverse conditions

  • Systems biology integration:

    • Multi-omics data integration to place yaiI in broader cellular context

    • Network analysis to predict functional relationships

These approaches represent the frontier of protein characterization, moving beyond traditional reductionist approaches to more holistic understanding.

How might computational approaches enhance experimental design for investigating yaiI?

Computational approaches can significantly enhance experimental design for yaiI research through:

  • Molecular dynamics simulations:

    • Model protein behavior in different environments

    • Predict conformational changes and potential binding sites

    • Guide mutagenesis experiments by identifying critical residues

  • Machine learning for experimental optimization:

    • Develop predictive models for expression and purification conditions

    • Optimize buffer compositions for stability and activity

    • Design efficient experimental sampling strategies

  • Network-based functional prediction:

    • Identify potential functional associations through guilt-by-association methods

    • Predict cellular pathways involving yaiI

    • Prioritize hypotheses for experimental testing

  • In silico screening:

    • Virtual screening for potential ligands or inhibitors

    • Molecular docking to predict binding modes

    • Filter compounds for experimental validation

This integrated computational-experimental approach embodies the "design cycle" principle where "theory and experiment alternate" to efficiently build understanding , thereby reducing the immense combinatorial complexity inherent in protein research.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.